In this study, we comprehensively evaluated the gene expression and protein levels of IL‐33, fetuin A, and CK‐18 in pericardial fluid (PF) and plasma of patients with CAD undergoing CABG. This evidence concerns the gene IL33 and coronary artery disorder.